title: Whither the roles of rifater and rifamate?
authors.affiliation: Department of Medicine, York Hospital, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: McConville
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D004338:Drug Combinations; C087181:isoniazid, pyrazinamide, rifampin drug combination; D011718:Pyrazinamide; C020800:Rifaprim; D014295:Trimethoprim; D007538:Isoniazid; D012293:Rifampin